Clinical trial

A Comparison of the Effectiveness and Safety of Topiramate and Phenytoin in…

NCT00210782 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry · Completed

Key facts

NCT number NCT00210782
Title A Comparison of the Effectiveness and Safety of Topiramate and Phenytoin in Patients With New Onset Epilepsy Requiring Rapid Initiation of Antiepileptic Drug Treatment
Official title A Double-blind Trial Comparing the Efficacy, Tolerability and Safety of Monotherapy Topiramate Versus Phenytoin in Subjects With Seizures Indicative of New Onset Epilepsy
Lead sponsor Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry
Collaborators Ortho-McNeil Neurologics, Inc. Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Epilepsy
Intervention type Drug
Interventions topiramate, phenytoin
Enrollment 262
Start date Jun 1, 2004
Completion Aug 1, 2007
First posted Sep 21, 2005
Last update posted Jun 10, 2011

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies